JP Stock MarketDetailed Quotes

206A Prism Biolab

Watchlist
  • 338
  • -4-1.17%
20min DelayMarket Closed Nov 29 15:30 JST
12.15BMarket Cap-22678P/E (Static)

Prism Biolab Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Mar 31, 2024
(FY)Sep 30, 2023
(FY)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
--2.96B
-32.82%1.13B
--1.69B
-Cash and cash equivalents
--2.96B
-32.82%1.13B
--1.69B
Receivables
--3.67M
----
--21.72M
-Accounts receivable
--3.67M
--0
--21.72M
-Gross accounts receivable
--3.67M
--0
--21.72M
Prepaid assets
----
-13.42%17.93M
--20.71M
Tax assets-Current
----
--40.25M
--0
Other current assets
--95.25M
223.16%5.48M
--1.7M
Total current assets
--3.06B
-30.86%1.2B
--1.73B
Non current assets
Net PPE
--0
--0
--0
-Gross PP&E
--72.48M
129.88%64.82M
--28.2M
-Accumulated depreciation
---72.48M
-129.89%-64.81M
---28.19M
Total investment
--27.46M
71.97%13.82M
--8.04M
-Other investment
--27.46M
71.97%13.82M
--8.04M
Total non current assets
--27.46M
71.97%13.82M
--8.04M
Total assets
--3.09B
-30.38%1.21B
--1.74B
Liabilities
Current liabilities
Payables
--20.77M
-27.31%39.81M
--54.77M
-Total tax payable
--20.77M
-95.47%1.21M
--26.7M
-Other payable
----
37.50%38.6M
--28.07M
Accrued and deferred income
--650.98M
161.91%18.22M
--6.96M
Other current liabilities
--102.75M
56.38%5.21M
--3.33M
Current liabilities
--774.5M
-2.79%63.24M
--65.06M
Non current liabilities
Held for sale liabilities-non current
--170K
0.00%170K
--170K
Other non current liabilities
--1K
-50.00%1K
--2K
Total non current liabilities
--171K
-0.58%171K
--172K
Total liabilities
--774.67M
-2.79%63.41M
--65.23M
Shareholders'equity
Share capital
--762.25M
0.00%12.25M
--12.25M
-common stock
--762.25M
0.00%12.25M
--12.25M
Additional paid-in capital
--2.38B
0.00%1.63B
--1.63B
Retained earnings
---829.27M
-1,563.86%-493.22M
--33.69M
Other equity interest
--423K
0.00%423K
--423K
Total stockholders'equity
--2.31B
-31.46%1.15B
--1.67B
Total equity
--2.31B
-31.46%1.15B
--1.67B
Currency Unit
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q2)Mar 31, 2024(FY)Sep 30, 2023(FY)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments --2.96B-32.82%1.13B--1.69B
-Cash and cash equivalents --2.96B-32.82%1.13B--1.69B
Receivables --3.67M------21.72M
-Accounts receivable --3.67M--0--21.72M
-Gross accounts receivable --3.67M--0--21.72M
Prepaid assets -----13.42%17.93M--20.71M
Tax assets-Current ------40.25M--0
Other current assets --95.25M223.16%5.48M--1.7M
Total current assets --3.06B-30.86%1.2B--1.73B
Non current assets
Net PPE --0--0--0
-Gross PP&E --72.48M129.88%64.82M--28.2M
-Accumulated depreciation ---72.48M-129.89%-64.81M---28.19M
Total investment --27.46M71.97%13.82M--8.04M
-Other investment --27.46M71.97%13.82M--8.04M
Total non current assets --27.46M71.97%13.82M--8.04M
Total assets --3.09B-30.38%1.21B--1.74B
Liabilities
Current liabilities
Payables --20.77M-27.31%39.81M--54.77M
-Total tax payable --20.77M-95.47%1.21M--26.7M
-Other payable ----37.50%38.6M--28.07M
Accrued and deferred income --650.98M161.91%18.22M--6.96M
Other current liabilities --102.75M56.38%5.21M--3.33M
Current liabilities --774.5M-2.79%63.24M--65.06M
Non current liabilities
Held for sale liabilities-non current --170K0.00%170K--170K
Other non current liabilities --1K-50.00%1K--2K
Total non current liabilities --171K-0.58%171K--172K
Total liabilities --774.67M-2.79%63.41M--65.23M
Shareholders'equity
Share capital --762.25M0.00%12.25M--12.25M
-common stock --762.25M0.00%12.25M--12.25M
Additional paid-in capital --2.38B0.00%1.63B--1.63B
Retained earnings ---829.27M-1,563.86%-493.22M--33.69M
Other equity interest --423K0.00%423K--423K
Total stockholders'equity --2.31B-31.46%1.15B--1.67B
Total equity --2.31B-31.46%1.15B--1.67B
Currency Unit JPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
% Chg

No Data